Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the early diagnosis of (a) Crohn’s disease and (b) ulcerative colitis.

To support healthcare professionals in the early diagnosis and management of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, the National Institute for Health and Care Excellence (NICE) has produced a range of guidance, including guidance specifically on the use of faecal calprotectin tests as a way of diagnosing inflammatory bowel disease (IBD). NICE’s IBD quality standard outlines that referral to a specialist assessment for suspected IBD should be within four weeks.

NICE guidelines represent best practice and health professionals, including general practitioners, and service commissioners are expected to take them fully into account. Guidelines published by NICE are not mandatory and do not replace the judgement of clinicians in determining the most appropriate treatment for individual patients.

In addition, NHS England’s Getting it Right First Time (GIRFT) specialty report on gastroenterology, published in September 2021, sets out actions and recommendations for the National Health Service to improve patient care and ensure consistency of care across the country.

It is the responsibility of integrated care boards to make available appropriate provision to meet the health and care needs of their local population, including the diagnosis and management of IBD.